Pathways to the diagnosis of ovarian cancer in the UK: a cohort study in primary care.

BJOG : an International Journal of Obstetrics and Gynaecology
J BarrettW Hamilton

Abstract

To identify the routes patients with ovarian cancer take between first symptom presentation and diagnosis. Cohort study. The study took place in 39 general practices in Devon, UK. All ovarian cancer patients identified in the practices, with a diagnosis between 2000 and 2007 inclusive. All patients had their cancer symptoms, referrals, and diagnoses identified and dated using their doctors' records. Numbers of patients taking specific routes to diagnosis, together with the time taken to diagnosis. Three main routes to diagnosis emerged. The first was the expected route of outpatient referral: 195 (92% of the total) had at least one of the seven ovarian cancer symptoms or an abdominal mass. A total of 123 (58%) were referred to a specialist, although only 65 (31%) were referred to a gynaecologist. Thirty-five (17%) were initially investigated within primary care by ultrasound scanning, and a further 35 (17%) were admitted as emergencies. The interval from first symptom to referral was similar across the different pathways, with a median (interquartile range) time between the first symptom presenting to primary care and first investigation or referral being 2.5 (0, 27.5) days. The median interval from first symptom reported in pr...Continue Reading

References

Nov 7, 2000·Cancer·B A GoffC H Melancon
Jun 25, 2003·Gynecologic Oncology·Marilyn F VineJoellen M Schildkraut
Jun 10, 2004·JAMA : the Journal of the American Medical Association·Barbara A GoffHoward G Muntz
Oct 27, 2004·International Journal of Cancer. Journal International Du Cancer·Freddie BrayCarlo La Vecchia
May 28, 2005·The Journal of Biological Chemistry·Marietta Flores-DíazMonica Thelestam
Jun 17, 2005·BJOG : an International Journal of Obstetrics and Gynaecology·Clare R BankheadJoan Austoker
Nov 16, 2005·Family Practice·Jacqueline BarrettWilliam Hamilton
Oct 5, 2006·Critical Reviews in Oncology/hematology·Nicoletta ColomboIgnace Vergote
Jan 20, 2007·BJOG : an International Journal of Obstetrics and Gynaecology·B D RuffordU Menon
Aug 24, 2007·The Lancet Oncology·Arduino VerdecchiaUNKNOWN EUROCARE-4 Working Group
May 20, 2008·BMC Family Practice·Jacqueline Barrett, William Hamilton
Sep 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lydia QuayeHonglin Song
Mar 24, 2009·Obstetrics and Gynecology·Edward PartridgeUNKNOWN PLCO Project Team
Aug 27, 2009·BMJ : British Medical Journal·William HamiltonDeborah Sharp
Sep 24, 2009·BMJ : British Medical Journal·C M SturgeonM J Duffy
Dec 4, 2009·British Journal of Cancer·M A Richards

❮ Previous
Next ❯

Citations

Sep 14, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Koji MatsuoNeil B Rosenshein
Jun 28, 2011·BMC Women's Health·Lene SeibaekLise Hounsgaard
May 28, 2013·The Journal of Family Planning and Reproductive Health Care·Scott Wilkes, Richard Edmondson
Jun 12, 2010·BJOG : an International Journal of Obstetrics and Gynaecology·D Parkin, M Cruickshank
Apr 7, 2016·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Vishal SharmaAndrew John Sutton
Nov 3, 2016·Nature Reviews. Clinical Oncology·Yin ZhouGeorgios Lyratzopoulos
Apr 26, 2017·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Gary A AbelGeorgios Lyratzopoulos
Jan 16, 2019·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Pauline WilliamsChristine Bond
Aug 12, 2018·Advances in Therapy·Samuel W D MerrielWillie Hamilton
May 6, 2021·International Journal of Environmental Research and Public Health·Aviane AugusteCarlene Radix

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the National Cancer Institute
Ilana Cass, Beth Y Karlan
Cancer Nursing
Dixie KoldjeskiMelvin Swanson
International Urogynecology Journal and Pelvic Floor Dysfunction
R P GoldbergH Beck
© 2021 Meta ULC. All rights reserved